Danica Chiu

Statistics

Publications

Citations

637

H-Index

Active since

2014

Affiliations

Regeneron (United States)(Current)

Memorial Sloan Kettering Cancer Center

Cornell University

Danica Chiu is an author at Regeneron (United States) specializing in bispecific antibody therapy, bispecific antibodies, and cd3-directed bispecific antibodies.

ORCID

Publications per year

2014–2022

Publications

A class of costimulatory CD28-bispecific antibodies that enhance the antitumor activity of CD3-bispecific antibodies

Dimitris Skokos, Janelle Waite, Lauric Haber et al. · Science Translational Medicine · 2020 · 153 citations

Life Sciences, Immunology, Oncology +16

A Mucin 16 bispecific T cell–engaging antibody for the treatment of ovarian cancer

Alison Crawford, Lauric Haber, Marcus P. Kelly et al. · Science Translational Medicine · 2019 · 141 citations · Full text

Medicine, Immunology, Oncology +17

Nontranscriptional Role of Hif-1α in Activation of γ-Secretase and Notch Signaling in Breast Cancer

Jennifer C. Villa, Danica Chiu, Alissa Brandes et al. · Cell Reports · 2014 · 126 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Generation of T-cell-redirecting bispecific antibodies with differentiated profiles of cytokine release and biodistribution by CD3 affinity tuning

Lauric Haber, Kara Olson, Marcus P. Kelly et al. · Scientific Reports · 2021 · 110 citations · Full text

Pharmacy, Immunology, Oncology +17

Hypoxia Inducible Factor-1α binds and activates γ-secretase for Aβ production under hypoxia and cerebral hypoperfusion

Courtney Alexander, Thomas Li, Yorito Hattori et al. · Molecular Psychiatry · 2022 · 56 citations · Full text

Medicine, Neurobiology, Neuroscience +16

1–5 of 6